Pieter van Paassen

6PUBLICATIONS
27CO-AUTHORS
AutoimmunityAllergyCardiology (incl. cardiovascular diseases)Molecular targetsRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 21, 2024
Cytotoxic T Cells Drive Outcome in Inflammatory Dilated Cardiomyopathy.

Maurits A Sikking, Daniel Harding, Michiel T H M Henkens

|Jul 27, 2024
High Prevalence of Myositis-Specific and Associated Antibodies in Patients with Pulmonary Hypertension.

Rachid Tobal, Judith Potjewijd, Daan van Doorn

|Dec 23, 2022
Annexin A1 Is Associated with Adverse Clinical Outcomes in Patients with COVID-19.

Matthias H Busch, Sjoerd A M E G Timmermans, Joop P Aendekerk

|Jan 14, 2022
The anti-C5a antibody vilobelimab efficiently inhibits C5a in patients with severe COVID-19.

Alexander P J Vlaar, Endry H T Lim, Sanne de Bruin

|Jul 24, 2021
The Syndromes of Thrombotic Microangiopathy: A Critical Appraisal on Complement Dysregulation.

Sjoerd A M E G Timmermans, Pieter van Paassen

Pageof 1